Greener Journal of Medical Sciences

By Owhonda G; Nnoka VN; Eli S; Ikenga VO; Wekere FCC; Emeghara GI; Tee GP (2022).

 

 

Prevalence of COVID–19/HIV-Positive Patients in an Isolation Center in Rivers State, Southern Nigeria.

 

 

Owhonda G¹; Nnoka VN²; Eli S³; Ikenga VO⁴; Wekere FCC¹; Emeghara GI⁵; Tee GP⁵

 

 

Department of community Medicine, Rivers State University.¹

Department of Pharmacology, Rivers State University.²

Mother, Baby and Adolescent Care Global Foundation.³

Department of Surgery, Rivers State University.⁴

Department of Human Physiology, Rivers State University.⁵

 

 

 

Return to Content

Full Text: PDF, HTML, EPUB, PHP

   

 

 

REFERENCES

 

1. Mirzaei H, McFarland W, Karamouzian M and Sharifi H (2020). COVID-19 among people living with HIV: A systematic review. AIDS Behav. 1-8. doi: 10.1007/s10461-020-02983-2

 

2. United States Agency for International Development (USAID). https://www.unaids.org/en/covid19

 

3. National Agency for the Control of AIDS (NACA), 2019. Nigeria prevalence rate. https://www.naca.gov.ng/nigeria-prevalence-rate/

 

4. Page J, Hinshaw D and McKay B (2021). "In Hunt for Covid-19 Origin, Patient Zero Points to Second Wuhan Market – The man with the first confirmed infection of the new coronavirus told the WHO team that his parents had shopped there". The Wall Street Journal.

 

5. Zimmer C (2021). "The Secret Life of a Coronavirus – An oily, 100-nanometer-wide bubble of genes has killed more than two million people and reshaped the world. Scientists don't quite know what to make of it". The New York Times.

 

6. McNeil Jr DG (2020). "Wuhan Coronavirus Looks Increasingly Like a Pandemic, Experts Say". The New York Times. ISSN 0362-4331.

 

7. World Health Organization (WHO), 2015. World Health Organization Best Practices for the Naming of New Human Infectious Diseases (PDF) (Report). hdl:10665/163636.

 

8. World Health Organization (WHO), 2020. Novel Coronavirus (2019-nCoV) Situation Report – 1" (PDF).

 

9. Coronavirus disease 2019 (COVID-19) in the EU/EEA and UK – eight update (PDF) (Report). ecdc. Archived (PDF) from the original on 14 March 2020. Retrieved 19 April, 2020

 

10. Nigeria COVID-19 update (2021).Nigerian Center for Disease Control (NCDC). https://covid19.ncdc.gov.ng/

 

11. Gandhi RT, Lynch JB, and Del Rio C (2020). "Mild or Moderate Covid-19". The New England Journal of Medicine. 383 (18): 1757–1766. doi:10.1056/NEJMcp2009249. PMID 32329974

 

12. Bohn MK, Lippi G, Horvath A, Sethi S, Koch D, Ferrari M, Wang C-B, Mancini N, Steele S and Adeli K (2020). Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med 58: 1037–1052. doi:10.1515/cclm-2020-0722.

 

13. Letko M, Marzi A, and Munster V (2020). Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol, 5: 562–569. doi:10.1038/s41564-020-0688-y.

 

14. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, Xiang Z, Mu Z, Chen X, Chen J, Hu K, Jin Q, Wang J and Qian Z (2020). Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun, 11: 1620. doi:10.1038/s41467-020-15562-9.

 

15. Eli S, Orluwene CG, Oku IY, Bob-Manuel M, Enyinnaya SO, Iyama AC, Nnoka VN and Emeghara GI (2022). Proposed treatment of COVID-19 infection in a poor resource setting – the use of medicinal extract from sunflower seed (Helianthus annuus seed). IJSRA, 05(01), 009-015.

 

16. Zou X, Chen K, Zou J, Han P,Hao J and Han Z (2020). Single-cell RNA-seq data analysis in the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCOV infection. Front Med;14(2):185-192.

 

17. Garg S, et al. Clinical trends among US hospitalized with COVID – 19. Ann Intern Med; 174(10): 1409-1419. Doi: 10.7326/M21-1991.

 

18. Mikami T, Miyashite H, Yanid T, et al (2021). Risk factors for mortality in patients with COVID – 19 in New York City. J GEN INTERN MED; 16:17-26.

 

19. Amakura Y, Yoshimura M, Yamakami S, and Yoshida T (2013). Isolation of phenolic constituents and characterization of antioxidant makers from sunflower (Helianthus annuus L.) seed extract. Phytochemistry Letters; 6(2): 302 – 305.

 

20. Kamal J (2011). Quantification of alkaloids, phenols, and flavonoids in sunflower (Helianthus annuus L.). Department of Biotechnology; 10(916): 3149 – 3151

 

21. Li MY, Li L, Zhang Y and Wang XS (2020). Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 9: 45. doi:10.1186/s40249-020-00662-x.

 

22. Salehi S, Abedi A, Balakrishnan S, and Gholamrezanezhad A (2020). "Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients". AJR. American Journal of Roentgenology. 215 (1): 87–93. doi:10.2214/AJR.20.23034.

 

23. Whigham LD, Watras AC and Schoeller DA (2007). Efficacy of conjugated linoleic acid for reducing fat mass: a meta – analysis in humans; American Journal of Clinical Nutrition; 85(5):1203 – 1211.

 

24. Centers for Disease Control and Prevention (2020). www.cdc.gov/media/releases/2020/archives.html

 

25. Gao F, Bailes E, Robertson D.L et al. (1999). Origin of HIV-1 in the chimpanzee pan troglodytes troglodytes. Nature, 397(6718):436-41.

 

26. Powell MK, Benková K, Selinger P, Dogoši M, Kinkorová Luňáčková I, Koutníková H, Laštíková J, Roubíčková A, Špůrková Z, Laclová L, Eis V, Šach J and Heneberg P (2016). "Opportunistic Infections in HIV-Infected Patients Differ Strongly in Frequencies and Spectra between Patients with Low CD4+ Cell Counts Examined Postmortem and Compensated Patients Examined Antemortem Irrespective of the HAART Era". PLOS ONE. 11 (9) doi:10.1371/journal.pone.0162704

 

27. World Health Organization (2021). HIV/AIDS. https://www.who.int/news-room/fact-sheets/detail/hiv-aids

 

28. Cunningham AL, Donaghy H, Harman AN, Kim M and Turville SG (2010). "Manipulation of dendritic cell function by viruses". Current Opinion in Microbiology. 13 (4): 524–9. doi:10.1016/j.mib.2010.06.002.

 

29. Garg H, Mohl J and Joshi A (2012). "HIV-1 induced bystander apoptosis". Viruses. 4 (11): 3020–43. doi:10.3390/v4113020

 

30. Kumar V (2012). Robbins Basic Pathology (9th ed.). p. 147. ISBN 978-1-4557-3787-1.

 

31. Karmen-Tuohy S, Carlucci P.M, Zervou F.N, Zacharioudakis I.M, Rebick G, Klein E, Reich J, Jones S, and Rahimian J (2020). Outcomes among HIV-Positive patients hospitalized with COVID-19. J Acquir Immune Defic Syndr; 85(1):6-10. DOI; 10.1097/QAI.0000000000002423.

 

32. Nagarakanti S.R, Okoh A.K and Bishburg E (2021). Clinical outcomes of patients with COVID-19 and HIV coinfection. J Med Virol, 93(3): 1687-1693. DOI: 10.1002/jmv.26533.

 

33. Oyelade T, Algaltani  JS, Hjazi AM, Li A, Kamila A;  Raya R P. Global and Regional Prevalence and Outcomes of COVID – 19 in people living with HIV: A Systematic Review and Meta – Analysis. Trop Med. Infect Dis. 2022 3; 7 (2): 22.

 

34. Algatitan JS, Aldhahiv AM, Oyelade T, Alghamdi SM, Almamary AS.  Smoking Cessation during COVID - 19. The top to – do list. Prim. Care Respire. Med 2021; 31: 1-3.

 

35. Yang J, Zheng Y, Guox, Puk, Chen Z, Guo Q, JiR, Wang Y Zhon Y. Prevalence of Comorbidities in the Novel Wuhan Coronanrns (Covid – 19) infection: A Systematic Review and Meta – Analysis, Int. J Infect. Dis 2020: 94: 91-95.

 

36. Seyed Alinghi S, et al. Prevalence of Covid – 19 like Symptoms among people living with HIV and using Anti Retroviral Therapy for  Preventing ad Treatment. Curr HIV Resp. 2020; 18(5): 373 – 380.

 

37. Shekhar R.et al. Coronavirus Disease of 2019 in patients with well – Controlled Human Immunodeficiency Virus on Antiretroviral Therapy. J Acquire Immune Defic Syn 2020; 85 (1): e1 – e4.

 

38. Seyed Alirighi  et al. Prevalence of Covid – 19 like Symptoms among People Living with HIV, and using Antiretroviral Therapy fo Prevention and Treatment Curr HIV Res 2020; 18 (5): 373 – 380.

 

39. The Virus That Changed Spain. Impact of COVID – 19 on people with HIV. Ballester – Amal. R, Gil –llaria M. Https://www.ncbi:nlm.nlm.Gov    (accessed 9/3/2022)